-
1
-
-
0029973585
-
Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea
-
Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, et al. (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. International journal of epidemiology 25: 933-940.
-
(1996)
International Journal of Epidemiology
, vol.25
, pp. 933-940
-
-
Shin, H.R.1
Lee, C.U.2
Park, H.J.3
Seol, S.Y.4
Chung, J.M.5
-
2
-
-
0029779857
-
Cholangiocarcinoma in patients with opisthorchiasis
-
Watanapa P, (1996) Cholangiocarcinoma in patients with opisthorchiasis. The British journal of surgery 83: 1062-1064.
-
(1996)
The British Journal of Surgery
, vol.83
, pp. 1062-1064
-
-
Watanapa, P.1
-
4
-
-
0036192231
-
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
-
Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, et al. (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. Journal of hepatology 36: 321-327.
-
(2002)
Journal of Hepatology
, vol.36
, pp. 321-327
-
-
Bergquist, A.1
Ekbom, A.2
Olsson, R.3
Kornfeldt, D.4
Loof, L.5
-
5
-
-
0031914317
-
Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study
-
Bergquist A, Glaumann H, Persson B, Broome U, (1998) Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27: 311-316.
-
(1998)
Hepatology
, vol.27
, pp. 311-316
-
-
Bergquist, A.1
Glaumann, H.2
Persson, B.3
Broome, U.4
-
6
-
-
1942440342
-
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis
-
Burak K, Angulo P, Pasha TM, Egan K, Petz J, et al. (2004) Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. The American journal of gastroenterology 99: 523-526.
-
(2004)
The American Journal of Gastroenterology
, vol.99
, pp. 523-526
-
-
Burak, K.1
Angulo, P.2
Pasha, T.M.3
Egan, K.4
Petz, J.5
-
7
-
-
56949093795
-
High lifetime risk of cancer in primary sclerosing cholangitis
-
Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR, (2009) High lifetime risk of cancer in primary sclerosing cholangitis. Journal of hepatology 50: 158-164.
-
(2009)
Journal of Hepatology
, vol.50
, pp. 158-164
-
-
Claessen, M.M.1
Vleggaar, F.P.2
Tytgat, K.M.3
Siersema, P.D.4
van Buuren, H.R.5
-
8
-
-
3843137261
-
Congenital choledochal cysts in adults
-
Visser BC, Suh I, Way LW, Kang SM, (2004) Congenital choledochal cysts in adults. Archives of surgery 139: 855-860 discussion 860-852.
-
(2004)
Archives of Surgery
, vol.139
, pp. 855-860
-
-
Visser, B.C.1
Suh, I.2
Way, L.W.3
Kang, S.M.4
-
9
-
-
40349103574
-
Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China
-
Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, et al. (2008) Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. International journal of cancer Journal international du cancer 122: 1849-1853.
-
(2008)
International Journal of Cancer Journal International Du Cancer
, vol.122
, pp. 1849-1853
-
-
Hsing, A.W.1
Zhang, M.2
Rashid, A.3
McGlynn, K.A.4
Wang, B.S.5
-
10
-
-
0034212347
-
Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis
-
Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, et al. (2000) Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 88: 2471-2477.
-
(2000)
Cancer
, vol.88
, pp. 2471-2477
-
-
Kobayashi, M.1
Ikeda, K.2
Saitoh, S.3
Suzuki, F.4
Tsubota, A.5
-
12
-
-
15744389434
-
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study
-
Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA, (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128: 620-626.
-
(2005)
Gastroenterology
, vol.128
, pp. 620-626
-
-
Shaib, Y.H.1
El-Serag, H.B.2
Davila, J.A.3
Morgan, R.4
McGlynn, K.A.5
-
13
-
-
34848893888
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study
-
Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 5: 1221-1228.
-
(2007)
Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association
, vol.5
, pp. 1221-1228
-
-
Welzel, T.M.1
Graubard, B.I.2
El-Serag, H.B.3
Shaib, Y.H.4
Hsing, A.W.5
-
14
-
-
4143131235
-
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
-
Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, et al. (2004) Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer science 95: 592-595.
-
(2004)
Cancer Science
, vol.95
, pp. 592-595
-
-
Yamamoto, S.1
Kubo, S.2
Hai, S.3
Uenishi, T.4
Yamamoto, T.5
-
15
-
-
0035683092
-
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy
-
Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, et al. (2001) Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer causes & control: CCC 12: 959-964.
-
(2001)
Cancer Causes & Control: CCC
, vol.12
, pp. 959-964
-
-
Donato, F.1
Gelatti, U.2
Tagger, A.3
Favret, M.4
Ribero, M.L.5
-
17
-
-
44449131763
-
Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study
-
Becker N, Liebermann D, Wesch H, Van Kaick G, (2008) Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study. European journal of cancer 44: 1259-1268.
-
(2008)
European Journal of Cancer
, vol.44
, pp. 1259-1268
-
-
Becker, N.1
Liebermann, D.2
Wesch, H.3
Van Kaick, G.4
-
18
-
-
0347384242
-
Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast
-
Travis LB, Hauptmann M, Gaul LK, Storm HH, Goldman MB, et al. (2003) Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiation research 160: 691-706.
-
(2003)
Radiation Research
, vol.160
, pp. 691-706
-
-
Travis, L.B.1
Hauptmann, M.2
Gaul, L.K.3
Storm, H.H.4
Goldman, M.B.5
-
19
-
-
26244441537
-
Cholangiocarcinoma
-
Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD, (2005) Cholangiocarcinoma. Lancet 366: 1303-1314.
-
(2005)
Lancet
, vol.366
, pp. 1303-1314
-
-
Khan, S.A.1
Thomas, H.C.2
Davidson, B.R.3
Taylor-Robinson, S.D.4
-
20
-
-
77950822827
-
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer
-
Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, et al. (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. The New England journal of medicine 362: 1273-1281.
-
(2010)
The New England Journal of Medicine
, vol.362
, pp. 1273-1281
-
-
Valle, J.1
Wasan, H.2
Palmer, D.H.3
Cunningham, D.4
Anthoney, A.5
-
21
-
-
0027771839
-
Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand
-
Kiba T, Tsuda H, Pairojkul C, Inoue S, Sugimura T, et al. (1993) Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Molecular carcinogenesis 8: 312-318.
-
(1993)
Molecular Carcinogenesis
, vol.8
, pp. 312-318
-
-
Kiba, T.1
Tsuda, H.2
Pairojkul, C.3
Inoue, S.4
Sugimura, T.5
-
22
-
-
0028725411
-
High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas
-
Ohashi K, Tsutsumi M, Nakajima Y, Noguchi O, Okita S, et al. (1994) High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas. Japanese journal of clinical oncology 24: 305-310.
-
(1994)
Japanese Journal of Clinical Oncology
, vol.24
, pp. 305-310
-
-
Ohashi, K.1
Tsutsumi, M.2
Nakajima, Y.3
Noguchi, O.4
Okita, S.5
-
23
-
-
0032014339
-
K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients
-
Petmitr S, Pinlaor S, Thousungnoen A, Karalak A, Migasena P, (1998) K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients. The Southeast Asian journal of tropical medicine and public health 29: 71-75.
-
(1998)
The Southeast Asian Journal of Tropical Medicine and Public Health
, vol.29
, pp. 71-75
-
-
Petmitr, S.1
Pinlaor, S.2
Thousungnoen, A.3
Karalak, A.4
Migasena, P.5
-
24
-
-
12344317992
-
[K-ras gene mutation in gallbladder carcinoma]
-
Roa JC, Roa I, de Aretxabala X, Melo A, Faria G, et al. (2004) [K-ras gene mutation in gallbladder carcinoma]. Revista medica de Chile 132: 955-960.
-
(2004)
Revista Medica De Chile
, vol.132
, pp. 955-960
-
-
Roa, J.C.1
Roa, I.2
de Aretxabala, X.3
Melo, A.4
Faria, G.5
-
25
-
-
0031796826
-
Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area
-
Sturm PD, Baas IO, Clement MJ, Nakeeb A, Johan G, et al. (1998) Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area. International journal of cancer Journal international du cancer 78: 695-698.
-
(1998)
International Journal of Cancer Journal International Du Cancer
, vol.78
, pp. 695-698
-
-
Sturm, P.D.1
Baas, I.O.2
Clement, M.J.3
Nakeeb, A.4
Johan, G.5
-
26
-
-
0025169651
-
Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing
-
Tada M, Omata M, Ohto M, (1990) Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer research 50: 1121-1124.
-
(1990)
Cancer Research
, vol.50
, pp. 1121-1124
-
-
Tada, M.1
Omata, M.2
Ohto, M.3
-
27
-
-
0025264589
-
[Detection of ras gene mutations of primary hepatic malignant tumors by polymerase chain reaction and direct sequencing method]
-
Tada M, Omata M, Ohto M, (1990) [Detection of ras gene mutations of primary hepatic malignant tumors by polymerase chain reaction and direct sequencing method]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 87: 811-815.
-
(1990)
Nihon Shokakibyo Gakkai Zasshi = The Japanese Journal of Gastro-Enterology
, vol.87
, pp. 811-815
-
-
Tada, M.1
Omata, M.2
Ohto, M.3
-
28
-
-
0026547213
-
High incidence of ras gene mutation in intrahepatic cholangiocarcinoma
-
Tada M, Omata M, Ohto M, (1992) High incidence of ras gene mutation in intrahepatic cholangiocarcinoma. Cancer 69: 1115-1118.
-
(1992)
Cancer
, vol.69
, pp. 1115-1118
-
-
Tada, M.1
Omata, M.2
Ohto, M.3
-
30
-
-
0034053517
-
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development
-
Boberg KM, Schrumpf E, Bergquist A, Broome U, Pares A, et al. (2000) Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. Journal of hepatology 32: 374-380.
-
(2000)
Journal of Hepatology
, vol.32
, pp. 374-380
-
-
Boberg, K.M.1
Schrumpf, E.2
Bergquist, A.3
Broome, U.4
Pares, A.5
-
31
-
-
0034050615
-
Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver
-
Tannapfel A, Weinans L, Geissler F, Schutz A, Katalinic A, et al. (2000) Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Digestive diseases and sciences 45: 317-324.
-
(2000)
Digestive Diseases and Sciences
, vol.45
, pp. 317-324
-
-
Tannapfel, A.1
Weinans, L.2
Geissler, F.3
Schutz, A.4
Katalinic, A.5
-
32
-
-
0033821601
-
New p53 mutations in hilar cholangiocarcinoma
-
Tullo A, D'Erchia AM, Honda K, Kelly MD, Habib NA, et al. (2000) New p53 mutations in hilar cholangiocarcinoma. European journal of clinical investigation 30: 798-803.
-
(2000)
European Journal of Clinical Investigation
, vol.30
, pp. 798-803
-
-
Tullo, A.1
D'Erchia, A.M.2
Honda, K.3
Kelly, M.D.4
Habib, N.A.5
-
33
-
-
0032520915
-
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma
-
Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, et al. (1998) Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer research 58: 1124-1126.
-
(1998)
Cancer Research
, vol.58
, pp. 1124-1126
-
-
Hahn, S.A.1
Bartsch, D.2
Schroers, A.3
Galehdari, H.4
Becker, M.5
-
34
-
-
1842481404
-
Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors
-
Iacobuzio-Donahue CA, Song J, Parmiagiani G, Yeo CJ, Hruban RH, et al. (2004) Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors. Clinical cancer research: an official journal of the American Association for Cancer Research 10: 1597-1604.
-
(2004)
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
, vol.10
, pp. 1597-1604
-
-
Iacobuzio-Donahue, C.A.1
Song, J.2
Parmiagiani, G.3
Yeo, C.J.4
Hruban, R.H.5
-
35
-
-
0033150246
-
Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma
-
Ahrendt SA, Eisenberger CF, Yip L, Rashid A, Chow JT, et al. (1999) Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. The Journal of surgical research 84: 88-93.
-
(1999)
The Journal of Surgical Research
, vol.84
, pp. 88-93
-
-
Ahrendt, S.A.1
Eisenberger, C.F.2
Yip, L.3
Rashid, A.4
Chow, J.T.5
-
36
-
-
37649015328
-
Two distinct pathways of p16 gene inactivation in gallbladder cancer
-
Tadokoro H, Shigihara T, Ikeda T, Takase M, Suyama M, (2007) Two distinct pathways of p16 gene inactivation in gallbladder cancer. World journal of gastroenterology: WJG 13: 6396-6403.
-
(2007)
World Journal of Gastroenterology: WJG
, vol.13
, pp. 6396-6403
-
-
Tadokoro, H.1
Shigihara, T.2
Ikeda, T.3
Takase, M.4
Suyama, M.5
-
37
-
-
0036771842
-
p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma
-
Taniai M, Higuchi H, Burgart LJ, Gores GJ, (2002) p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. Gastroenterology 123: 1090-1098.
-
(2002)
Gastroenterology
, vol.123
, pp. 1090-1098
-
-
Taniai, M.1
Higuchi, H.2
Burgart, L.J.3
Gores, G.J.4
-
38
-
-
0033756536
-
Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver
-
Tannapfel A, Benicke M, Katalinic A, Uhlmann D, Kockerling F, et al. (2000) Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 47: 721-727.
-
(2000)
Gut
, vol.47
, pp. 721-727
-
-
Tannapfel, A.1
Benicke, M.2
Katalinic, A.3
Uhlmann, D.4
Kockerling, F.5
-
39
-
-
0028981089
-
Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers
-
Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, et al. (1995) Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer research 55: 2756-2760.
-
(1995)
Cancer Research
, vol.55
, pp. 2756-2760
-
-
Yoshida, S.1
Todoroki, T.2
Ichikawa, Y.3
Hanai, S.4
Suzuki, H.5
-
40
-
-
84856298658
-
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping
-
Borger DR, Tanabe KK, Fan KC, Lopez HU, Fantin VR, et al. (2012) Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. The oncologist 17: 72-79.
-
(2012)
The Oncologist
, vol.17
, pp. 72-79
-
-
Borger, D.R.1
Tanabe, K.K.2
Fan, K.C.3
Lopez, H.U.4
Fantin, V.R.5
-
41
-
-
84866504465
-
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
-
Kipp BR, Voss JS, Kerr SE, Barr Fritcher EG, Graham RP, et al. (2012) Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma. Human pathology 43: 1552-1558.
-
(2012)
Human Pathology
, vol.43
, pp. 1552-1558
-
-
Kipp, B.R.1
Voss, J.S.2
Kerr, S.E.3
Barr Fritcher, E.G.4
Graham, R.P.5
-
42
-
-
79251579592
-
Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma
-
Gu TL, Deng X, Huang F, Tucker M, Crosby K, et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PloS one 6: e15640.
-
(2011)
PloS One
, vol.6
-
-
Gu, T.L.1
Deng, X.2
Huang, F.3
Tucker, M.4
Crosby, K.5
-
43
-
-
27144523155
-
Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas
-
Gwak GY, Yoon JH, Shin CM, Ahn YJ, Chung JK, et al. (2005) Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas. Journal of cancer research and clinical oncology 131: 649-652.
-
(2005)
Journal of Cancer Research and Clinical Oncology
, vol.131
, pp. 649-652
-
-
Gwak, G.Y.1
Yoon, J.H.2
Shin, C.M.3
Ahn, Y.J.4
Chung, J.K.5
-
44
-
-
33645689431
-
Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma
-
Leone F, Cavalloni G, Pignochino Y, Sarotto I, Ferraris R, et al. (2006) Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research 12: 1680-1685.
-
(2006)
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
, vol.12
, pp. 1680-1685
-
-
Leone, F.1
Cavalloni, G.2
Pignochino, Y.3
Sarotto, I.4
Ferraris, R.5
-
45
-
-
0037624602
-
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
-
Tannapfel A, Sommerer F, Benicke M, Katalinic A, Uhlmann D, et al. (2003) Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut 52: 706-712.
-
(2003)
Gut
, vol.52
, pp. 706-712
-
-
Tannapfel, A.1
Sommerer, F.2
Benicke, M.3
Katalinic, A.4
Uhlmann, D.5
-
46
-
-
79551682846
-
Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
-
Deshpande V, Nduaguba A, Zimmerman SM, Kehoe SM, Macconaill LE, et al. (2011) Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma. BMC cancer 11: 60.
-
(2011)
BMC Cancer
, vol.11
, pp. 60
-
-
Deshpande, V.1
Nduaguba, A.2
Zimmerman, S.M.3
Kehoe, S.M.4
Macconaill, L.E.5
-
47
-
-
41349115671
-
Rare PIK3CA hotspot mutations in carcinomas of the biliary tract
-
Riener MO, Bawohl M, Clavien PA, Jochum W, (2008) Rare PIK3CA hotspot mutations in carcinomas of the biliary tract. Genes, chromosomes & cancer 47: 363-367.
-
(2008)
Genes, Chromosomes & Cancer
, vol.47
, pp. 363-367
-
-
Riener, M.O.1
Bawohl, M.2
Clavien, P.A.3
Jochum, W.4
-
48
-
-
84860343739
-
Aspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations
-
Wendum D, Barbu V, Rosmorduc O, Arrive L, Flejou JF, et al. (2012) Aspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations. Virchows Archiv: an international journal of pathology 460: 291-298.
-
(2012)
Virchows Archiv: An International Journal of Pathology
, vol.460
, pp. 291-298
-
-
Wendum, D.1
Barbu, V.2
Rosmorduc, O.3
Arrive, L.4
Flejou, J.F.5
-
49
-
-
34247177532
-
Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma
-
Scheimann AO, Strautnieks SS, Knisely AS, Byrne JA, Thompson RJ, et al. (2007) Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma. The Journal of pediatrics 150: 556-559.
-
(2007)
The Journal of Pediatrics
, vol.150
, pp. 556-559
-
-
Scheimann, A.O.1
Strautnieks, S.S.2
Knisely, A.S.3
Byrne, J.A.4
Thompson, R.J.5
-
50
-
-
41549123313
-
Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families
-
Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerova D, Rayner A, et al. (2008) Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 134: 1203-1214.
-
(2008)
Gastroenterology
, vol.134
, pp. 1203-1214
-
-
Strautnieks, S.S.1
Byrne, J.A.2
Pawlikowska, L.3
Cebecauerova, D.4
Rayner, A.5
-
51
-
-
0035093749
-
E-cadherin gene mutations in human intrahepatic cholangiocarcinoma
-
Endo K, Ashida K, Miyake N, Terada T, (2001) E-cadherin gene mutations in human intrahepatic cholangiocarcinoma. The Journal of pathology 193: 310-317.
-
(2001)
The Journal of Pathology
, vol.193
, pp. 310-317
-
-
Endo, K.1
Ashida, K.2
Miyake, N.3
Terada, T.4
-
52
-
-
0036623359
-
Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry
-
Ukita Y, Kato M, Terada T, (2002) Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry. Journal of hepatology 36: 780-785.
-
(2002)
Journal of Hepatology
, vol.36
, pp. 780-785
-
-
Ukita, Y.1
Kato, M.2
Terada, T.3
-
53
-
-
84896492774
-
FGFR2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma
-
doi:[], 10.1002/hep.26890. [Epub ahead of print]
-
Arai Y, Totoki Y, Hosoda F, Shirota T, Hama N, et al. (2013) FGFR2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology 2013 Oct 9doi:[]10.1002/hep.26890. [Epub ahead of print].
-
(2013)
Hepatology
, vol.2013
-
-
Arai, Y.1
Totoki, Y.2
Hosoda, F.3
Shirota, T.4
Hama, N.5
-
54
-
-
84878781242
-
Identification of targetable FGFR gene fusions in diverse cancers
-
Wu YM, Su F, Kalyana-Sundaram S, Khazanov N, Ateeq B, et al. (2013) Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discov 3: 636-647.
-
(2013)
Cancer Discov
, vol.3
, pp. 636-647
-
-
Wu, Y.M.1
Su, F.2
Kalyana-Sundaram, S.3
Khazanov, N.4
Ateeq, B.5
-
55
-
-
0035026704
-
Predicting deleterious amino acid substitutions
-
Ng PC, Henikoff S, (2001) Predicting deleterious amino acid substitutions. Genome Res 11: 863-874.
-
(2001)
Genome Res
, vol.11
, pp. 863-874
-
-
Ng, P.C.1
Henikoff, S.2
-
56
-
-
77951640946
-
A method and server for predicting damaging missense mutations
-
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
-
(2010)
Nat Methods
, vol.7
, pp. 248-249
-
-
Adzhubei, I.A.1
Schmidt, S.2
Peshkin, L.3
Ramensky, V.E.4
Gerasimova, A.5
-
57
-
-
44949137643
-
Determinants of protein function revealed by combinatorial entropy optimization
-
Reva B, Antipin Y, Sander C, (2007) Determinants of protein function revealed by combinatorial entropy optimization. Genome Biol 8: R232.
-
(2007)
Genome Biol
, vol.8
-
-
Reva, B.1
Antipin, Y.2
Sander, C.3
-
58
-
-
77955151784
-
MutationTaster evaluates disease-causing potential of sequence alterations
-
Schwarz JM, Rodelsperger C, Schuelke M, Seelow D, (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7: 575-576.
-
(2010)
Nat Methods
, vol.7
, pp. 575-576
-
-
Schwarz, J.M.1
Rodelsperger, C.2
Schuelke, M.3
Seelow, D.4
-
59
-
-
84872585155
-
Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities
-
Craig DW, O'Shaughnessy JA, Kiefer JA, Aldrich J, Sinari S, et al. (2013) Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Mol Cancer Ther 12: 104-116.
-
(2013)
Mol Cancer Ther
, vol.12
, pp. 104-116
-
-
Craig, D.W.1
O'Shaughnessy, J.A.2
Kiefer, J.A.3
Aldrich, J.4
Sinari, S.5
-
61
-
-
0037393850
-
A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
-
Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, et al. (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9: 407-415.
-
(2003)
Nat Med
, vol.9
, pp. 407-415
-
-
Qi, J.H.1
Ebrahem, Q.2
Moore, N.3
Murphy, G.4
Claesson-Welsh, L.5
-
62
-
-
84860807231
-
Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis
-
Salvucci O, Tosato G, (2012) Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res 114: 21-57.
-
(2012)
Adv Cancer Res
, vol.114
, pp. 21-57
-
-
Salvucci, O.1
Tosato, G.2
-
63
-
-
1042267263
-
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
-
Cavallaro U, Christofori G, (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 118-132
-
-
Cavallaro, U.1
Christofori, G.2
-
64
-
-
84857692095
-
Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia
-
Kraus MR, Clauin S, Pfister Y, Di Maio M, Ulinski T, et al. (2012) Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia. Hum Mutat 33: 86-90.
-
(2012)
Hum Mutat
, vol.33
, pp. 86-90
-
-
Kraus, M.R.1
Clauin, S.2
Pfister, Y.3
Di Maio, M.4
Ulinski, T.5
-
65
-
-
77957829001
-
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer
-
Wang X, Osada T, Wang Y, Yu L, Sakakura K, et al. (2010) CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst 102: 1496-1512.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 1496-1512
-
-
Wang, X.1
Osada, T.2
Wang, Y.3
Yu, L.4
Sakakura, K.5
-
66
-
-
84858148966
-
Gene expression of O-GlcNAc cycling enzymes in human breast cancers
-
Krzeslak A, Forma E, Bernaciak M, Romanowicz H, Brys M, (2012) Gene expression of O-GlcNAc cycling enzymes in human breast cancers. Clin Exp Med 12: 61-65.
-
(2012)
Clin Exp Med
, vol.12
, pp. 61-65
-
-
Krzeslak, A.1
Forma, E.2
Bernaciak, M.3
Romanowicz, H.4
Brys, M.5
-
67
-
-
80051554317
-
Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor
-
Antonescu CR, Zhang L, Nielsen GP, Rosenberg AE, Dal Cin P, et al. (2011) Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes Chromosomes Cancer 50: 757-764.
-
(2011)
Genes Chromosomes Cancer
, vol.50
, pp. 757-764
-
-
Antonescu, C.R.1
Zhang, L.2
Nielsen, G.P.3
Rosenberg, A.E.4
Dal Cin, P.5
-
68
-
-
64549137103
-
Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions
-
Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, et al. (2009) Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol 217: 716-727.
-
(2009)
J Pathol
, vol.217
, pp. 716-727
-
-
Hallor, K.H.1
Sciot, R.2
Staaf, J.3
Heidenblad, M.4
Rydholm, A.5
-
69
-
-
70449523183
-
Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
-
Kumar R, Crouthamel MC, Rominger DH, Gontarek RR, Tummino PJ, et al. (2009) Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors. Br J Cancer 101: 1717-1723.
-
(2009)
Br J Cancer
, vol.101
, pp. 1717-1723
-
-
Kumar, R.1
Crouthamel, M.C.2
Rominger, D.H.3
Gontarek, R.R.4
Tummino, P.J.5
-
70
-
-
84875273076
-
TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways
-
Ha GH, Park JS, Breuer EK, (2013) TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Cancer Lett 332: 63-73.
-
(2013)
Cancer Lett
, vol.332
, pp. 63-73
-
-
Ha, G.H.1
Park, J.S.2
Breuer, E.K.3
-
71
-
-
75149170979
-
Fibroblast growth factor signalling: from development to cancer
-
Turner N, Grose R, (2010) Fibroblast growth factor signalling: from development to cancer. Nature reviews Cancer 10: 116-129.
-
(2010)
Nature Reviews Cancer
, vol.10
, pp. 116-129
-
-
Turner, N.1
Grose, R.2
-
72
-
-
84873045850
-
Oncogenic FGFR3 gene fusions in bladder cancer. Human molecular genetics
-
Williams SV, Hurst CD, Knowles MA, (2012) Oncogenic FGFR3 gene fusions in bladder cancer. Human molecular genetics. Hum Mol Genet 22: 795-803.
-
(2012)
Hum Mol Genet
, vol.22
, pp. 795-803
-
-
Williams, S.V.1
Hurst, C.D.2
Knowles, M.A.3
-
73
-
-
14944369975
-
Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML
-
Maeda T, Yagasaki F, Ishikawa M, Takahashi N, Bessho M, (2005) Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML. Blood 105: 2115-2123.
-
(2005)
Blood
, vol.105
, pp. 2115-2123
-
-
Maeda, T.1
Yagasaki, F.2
Ishikawa, M.3
Takahashi, N.4
Bessho, M.5
-
74
-
-
82655179976
-
Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases
-
Ren M, Qin H, Ren R, Tidwell J, Cowell JK, (2011) Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases. Cancer research 71: 7312-7322.
-
(2011)
Cancer Research
, vol.71
, pp. 7312-7322
-
-
Ren, M.1
Qin, H.2
Ren, R.3
Tidwell, J.4
Cowell, J.K.5
-
75
-
-
84901740768
-
Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities
-
Ren M, Qin H, Ren R, Cowell JK (2012) Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK.
-
(2012)
Leukemia: Official journal of the Leukemia Society of America, Leukemia Research Fund, UK
-
-
Ren, M.1
Qin, H.2
Ren, R.3
Cowell, J.K.4
-
76
-
-
0030842266
-
A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene
-
Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, et al. (1997) A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood 90: 4062-4070.
-
(1997)
Blood
, vol.90
, pp. 4062-4070
-
-
Richelda, R.1
Ronchetti, D.2
Baldini, L.3
Cro, L.4
Viggiano, L.5
-
77
-
-
47949114797
-
Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders
-
Cross NC, Reiter A, (2008) Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders. Acta haematologica 119: 199-206.
-
(2008)
Acta Haematologica
, vol.119
, pp. 199-206
-
-
Cross, N.C.1
Reiter, A.2
-
78
-
-
84865805666
-
Transforming fusions of FGFR and TACC genes in human glioblastoma
-
Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, et al. (2012) Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337: 1231-1235.
-
(2012)
Science
, vol.337
, pp. 1231-1235
-
-
Singh, D.1
Chan, J.M.2
Zoppoli, P.3
Niola, F.4
Sullivan, R.5
-
79
-
-
84879418850
-
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
-
Wang P, Dong Q, Zhang C, Kuan PF, Liu Y, et al. (2012) Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32: 3091-100.
-
(2012)
Oncogene
, vol.32
, pp. 3091-3100
-
-
Wang, P.1
Dong, Q.2
Zhang, C.3
Kuan, P.F.4
Liu, Y.5
-
80
-
-
69049097145
-
Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow
-
Maisonneuve C, Guilleret I, Vick P, Weber T, Andre P, et al. (2009) Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow. Development 136: 3019-3030.
-
(2009)
Development
, vol.136
, pp. 3019-3030
-
-
Maisonneuve, C.1
Guilleret, I.2
Vick, P.3
Weber, T.4
Andre, P.5
-
81
-
-
0344445675
-
A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning
-
Petiot A, Conti FJ, Grose R, Revest JM, Hodivala-Dilke KM, et al. (2003) A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. Development 130: 5493-5501.
-
(2003)
Development
, vol.130
, pp. 5493-5501
-
-
Petiot, A.1
Conti, F.J.2
Grose, R.3
Revest, J.M.4
Hodivala-Dilke, K.M.5
-
82
-
-
0030665570
-
Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells
-
Feng S, Wang F, Matsubara A, Kan M, McKeehan WL, (1997) Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 57: 5369-5378.
-
(1997)
Cancer Res
, vol.57
, pp. 5369-5378
-
-
Feng, S.1
Wang, F.2
Matsubara, A.3
Kan, M.4
McKeehan, W.L.5
-
83
-
-
0033518110
-
Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer
-
Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, et al. (1999) Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene 18: 7234-7243.
-
(1999)
Oncogene
, vol.18
, pp. 7234-7243
-
-
Ricol, D.1
Cappellen, D.2
El Marjou, A.3
Gil-Diez-de-Medina, S.4
Girault, J.M.5
-
84
-
-
0030812901
-
Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations
-
Lorenzi MV, Castagnino P, Chen Q, Chedid M, Miki T, (1997) Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations. Oncogene 15: 817-826.
-
(1997)
Oncogene
, vol.15
, pp. 817-826
-
-
Lorenzi, M.V.1
Castagnino, P.2
Chen, Q.3
Chedid, M.4
Miki, T.5
-
85
-
-
36348943566
-
Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome
-
Chase A, Grand FH, Cross NC, (2007) Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. Blood 110: 3729-3734.
-
(2007)
Blood
, vol.110
, pp. 3729-3734
-
-
Chase, A.1
Grand, F.H.2
Cross, N.C.3
-
86
-
-
84871491773
-
FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor
-
Guagnano V, Kauffmann A, Wohrle S, Stamm C, Ito M, et al. (2012) FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor. Cancer discovery 2: 1118-1133.
-
(2012)
Cancer Discovery
, vol.2
, pp. 1118-1133
-
-
Guagnano, V.1
Kauffmann, A.2
Wohrle, S.3
Stamm, C.4
Ito, M.5
-
87
-
-
84859402751
-
Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models
-
Gozgit JM, Wong MJ, Moran L, Wardwell S, Mohemmad QK, et al. (2012) Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models. Molecular cancer therapeutics 11: 690-699.
-
(2012)
Molecular Cancer Therapeutics
, vol.11
, pp. 690-699
-
-
Gozgit, J.M.1
Wong, M.J.2
Moran, L.3
Wardwell, S.4
Mohemmad, Q.K.5
-
88
-
-
78650231488
-
Significance of keratinocyte growth factor receptor in the proliferation of biliary tract cancer
-
Amano R, Yamada N, Doi Y, Yashiro M, Ohira M, et al. (2010) Significance of keratinocyte growth factor receptor in the proliferation of biliary tract cancer. Anticancer Res 30: 4115-4121.
-
(2010)
Anticancer Res
, vol.30
, pp. 4115-4121
-
-
Amano, R.1
Yamada, N.2
Doi, Y.3
Yashiro, M.4
Ohira, M.5
-
89
-
-
34447322566
-
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
-
Kumar R, Knick VB, Rudolph SK, Johnson JH, Crosby RM, et al. (2007) Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Mol Cancer Ther 6: 2012-2021.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 2012-2021
-
-
Kumar, R.1
Knick, V.B.2
Rudolph, S.K.3
Johnson, J.H.4
Crosby, R.M.5
-
90
-
-
27544450547
-
Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype
-
Ballaro C, Ceccarelli S, Tiveron C, Tatangelo L, Salvatore AM, et al. (2005) Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype. EMBO reports 6: 755-761.
-
(2005)
EMBO Reports
, vol.6
, pp. 755-761
-
-
Ballaro, C.1
Ceccarelli, S.2
Tiveron, C.3
Tatangelo, L.4
Salvatore, A.M.5
-
91
-
-
33646588346
-
Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation
-
Ferby I, Reschke M, Kudlacek O, Knyazev P, Pante G, et al. (2006) Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nature medicine 12: 568-573.
-
(2006)
Nature Medicine
, vol.12
, pp. 568-573
-
-
Ferby, I.1
Reschke, M.2
Kudlacek, O.3
Knyazev, P.4
Pante, G.5
-
92
-
-
66649098123
-
Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease
-
Jeong JW, Lee HS, Lee KY, White LD, Broaddus RR, et al. (2009) Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease. Proceedings of the National Academy of Sciences of the United States of America 106: 8677-8682.
-
(2009)
Proceedings of the National Academy of Sciences of the United States of America
, vol.106
, pp. 8677-8682
-
-
Jeong, J.W.1
Lee, H.S.2
Lee, K.Y.3
White, L.D.4
Broaddus, R.R.5
-
93
-
-
79952297518
-
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer
-
Lin CI, Du J, Shen WT, Whang EE, Donner DB, et al. (2011) Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer. The Journal of clinical endocrinology and metabolism 96: E554-565.
-
(2011)
The Journal of Clinical Endocrinology and Metabolism
, vol.96
-
-
Lin, C.I.1
Du, J.2
Shen, W.T.3
Whang, E.E.4
Donner, D.B.5
-
94
-
-
77950602115
-
Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma
-
Reschke M, Ferby I, Stepniak E, Seitzer N, Horst D, et al. (2010) Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma. Hepatology 51: 1383-1390.
-
(2010)
Hepatology
, vol.51
, pp. 1383-1390
-
-
Reschke, M.1
Ferby, I.2
Stepniak, E.3
Seitzer, N.4
Horst, D.5
-
95
-
-
0038037236
-
Feedback inhibition by RALT controls signal output by the ErbB network
-
Anastasi S, Fiorentino L, Fiorini M, Fraioli R, Sala G, et al. (2003) Feedback inhibition by RALT controls signal output by the ErbB network. Oncogene 22: 4221-4234.
-
(2003)
Oncogene
, vol.22
, pp. 4221-4234
-
-
Anastasi, S.1
Fiorentino, L.2
Fiorini, M.3
Fraioli, R.4
Sala, G.5
-
96
-
-
36749011864
-
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
-
Zhang X, Pickin KA, Bose R, Jura N, Cole PA, et al. (2007) Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450: 741-744.
-
(2007)
Nature
, vol.450
, pp. 741-744
-
-
Zhang, X.1
Pickin, K.A.2
Bose, R.3
Jura, N.4
Cole, P.A.5
-
97
-
-
77951785332
-
A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation
-
Frosi Y, Anastasi S, Ballaro C, Varsano G, Castellani L, et al. (2010) A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation. The Journal of cell biology 189: 557-571.
-
(2010)
The Journal of Cell Biology
, vol.189
, pp. 557-571
-
-
Frosi, Y.1
Anastasi, S.2
Ballaro, C.3
Varsano, G.4
Castellani, L.5
-
98
-
-
22744445536
-
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin
-
Anastasi S, Sala G, Huiping C, Caprini E, Russo G, et al. (2005) Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin. Oncogene 24: 4540-4548.
-
(2005)
Oncogene
, vol.24
, pp. 4540-4548
-
-
Anastasi, S.1
Sala, G.2
Huiping, C.3
Caprini, E.4
Russo, G.5
-
99
-
-
78649823233
-
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
-
Duncan CG, Killela PJ, Payne CA, Lampson B, Chen WC, et al. (2010) Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes. Oncotarget 1: 265-277.
-
(2010)
Oncotarget
, vol.1
, pp. 265-277
-
-
Duncan, C.G.1
Killela, P.J.2
Payne, C.A.3
Lampson, B.4
Chen, W.C.5
-
100
-
-
77951061655
-
Mig-6 controls EGFR trafficking and suppresses gliomagenesis
-
Ying H, Zheng H, Scott K, Wiedemeyer R, Yan H, et al. (2010) Mig-6 controls EGFR trafficking and suppresses gliomagenesis. Proceedings of the National Academy of Sciences of the United States of America 107: 6912-6917.
-
(2010)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, pp. 6912-6917
-
-
Ying, H.1
Zheng, H.2
Scott, K.3
Wiedemeyer, R.4
Yan, H.5
-
101
-
-
84861863346
-
Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling
-
Li Z, Dong Q, Wang Y, Qu L, Qiu X, et al. (2012) Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling. Molecular carcinogenesis 51: 522-534.
-
(2012)
Molecular Carcinogenesis
, vol.51
, pp. 522-534
-
-
Li, Z.1
Dong, Q.2
Wang, Y.3
Qu, L.4
Qiu, X.5
-
102
-
-
84862216069
-
Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation
-
Zhang YW, Staal B, Dykema KJ, Furge KA, Vande Woude GF, (2012) Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. PloS one 7: e38955.
-
(2012)
PloS One
, vol.7
-
-
Zhang, Y.W.1
Staal, B.2
Dykema, K.J.3
Furge, K.A.4
Vande Woude, G.F.5
-
103
-
-
33846215432
-
Evidence that MIG-6 is a tumor-suppressor gene
-
Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, et al. (2007) Evidence that MIG-6 is a tumor-suppressor gene. Oncogene 26: 269-276.
-
(2007)
Oncogene
, vol.26
, pp. 269-276
-
-
Zhang, Y.W.1
Staal, B.2
Su, Y.3
Swiatek, P.4
Zhao, P.5
-
104
-
-
77957331045
-
GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling
-
Bai A, Meetze K, Vo NY, Kollipara S, Mazsa EK, et al. (2010) GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling. Cancer Res 70: 7630-7639.
-
(2010)
Cancer Res
, vol.70
, pp. 7630-7639
-
-
Bai, A.1
Meetze, K.2
Vo, N.Y.3
Kollipara, S.4
Mazsa, E.K.5
-
105
-
-
84876963318
-
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs
-
Christoforides A, Carpten JD, Weiss GJ, Demeure MJ, Von Hoff DD, et al. (2013) Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. BMC Genomics 14: 302.
-
(2013)
BMC Genomics
, vol.14
, pp. 302
-
-
Christoforides, A.1
Carpten, J.D.2
Weiss, G.J.3
Demeure, M.J.4
Von Hoff, D.D.5
-
106
-
-
80051507403
-
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
-
Kim D, Salzberg SL, (2011) TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol 12: R72.
-
(2011)
Genome Biol
, vol.12
-
-
Kim, D.1
Salzberg, S.L.2
-
107
-
-
80054003528
-
ChimeraScan: a tool for identifying chimeric transcription in sequencing data
-
Iyer MK, Chinnaiyan AM, Maher CA, (2011) ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27: 2903-2904.
-
(2011)
Bioinformatics
, vol.27
, pp. 2903-2904
-
-
Iyer, M.K.1
Chinnaiyan, A.M.2
Maher, C.A.3
-
108
-
-
79957829805
-
deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data
-
McPherson A, Hormozdiari F, Zayed A, Giuliany R, Ha G, et al. (2011) deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol 7: e1001138.
-
(2011)
PLoS Comput Biol
, vol.7
-
-
McPherson, A.1
Hormozdiari, F.2
Zayed, A.3
Giuliany, R.4
Ha, G.5
-
109
-
-
80055071248
-
A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines
-
Asmann YW, Hossain A, Necela BM, Middha S, Kalari KR, et al. (2011) A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res 39: e100.
-
(2011)
Nucleic Acids Res
, vol.39
-
-
Asmann, Y.W.1
Hossain, A.2
Necela, B.M.3
Middha, S.4
Kalari, K.R.5
-
110
-
-
84857769158
-
Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells
-
Diep CH, Zucker KM, Hostetter G, Watanabe A, Hu C, et al. (2012) Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells. PLoS One 7: e32783.
-
(2012)
PLoS One
, vol.7
-
-
Diep, C.H.1
Zucker, K.M.2
Hostetter, G.3
Watanabe, A.4
Hu, C.5
-
111
-
-
84861581233
-
Exome sequencing of liver fluke-associated cholangiocarcinoma
-
Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, et al. (2012) Exome sequencing of liver fluke-associated cholangiocarcinoma. Nature genetics 44: 690-693.
-
(2012)
Nature Genetics
, vol.44
, pp. 690-693
-
-
Ong, C.K.1
Subimerb, C.2
Pairojkul, C.3
Wongkham, S.4
Cutcutache, I.5
-
112
-
-
84869091997
-
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
-
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, et al. (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491: 399-405.
-
(2012)
Nature
, vol.491
, pp. 399-405
-
-
Biankin, A.V.1
Waddell, N.2
Kassahn, K.S.3
Gingras, M.C.4
Muthuswamy, L.B.5
-
113
-
-
84861625981
-
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
-
Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, et al. (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature genetics 44: 694-698.
-
(2012)
Nature Genetics
, vol.44
, pp. 694-698
-
-
Guichard, C.1
Amaddeo, G.2
Imbeaud, S.3
Ladeiro, Y.4
Pelletier, L.5
|